This is a working overview of Water activity, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-05-12. Anything still debated is marked as such rather than presented as settled.
Routine quality control for hydrolysate powders includes total nitrogen or protein content by Kjeldahl or Dumas combustion, moisture by oven or Karl Fischer titration, ash, and mineral profiles. Microbiological tests typically cover total aerobic counts, yeasts, molds, and specified pathogens according to regional food safety rules. Amino acid analysis can quantify free amino acids and peptide-bound residues after hydrolysis. For products intended for special populations, additional tests may target residual lactose, fat, or specific allergenic proteins. Specifications are set by the manufacturer and may exceed general food-grade requirements.
Hydrolysate powders are hygroscopic and can absorb moisture during storage, which may promote caking, browning, and loss of solubility. Cool, dry conditions and sealed packaging slow these changes, while high humidity and warm temperatures accelerate Maillard reactions between peptides and residual sugars. Liquid hydrolysates are more perishable and often require refrigeration or preservatives. Shelf-life studies usually monitor moisture, color, solubility, free amino groups, and microbial load over time. Stability depends on residual lactose, water activity, packaging barrier properties, and the initial peptide profile.
Physical properties such as particle size, bulk density, and reconstitution behavior affect handling and finished product quality. Water activity and moisture content influence shelf life; high moisture can promote caking, browning, and microbial growth. Color is monitored because Maillard reactions between peptides and reducing sugars can darken the powder during storage. Taste panels and instrumental methods may assess bitterness, which is a common challenge for hydrolysates. Specifications often include limits for heavy metals, microbiological counts, and residual fat, depending on the intended market.
Quality control for hydrolyzed whey protein focuses on composition, peptide size, and batch consistency. Protein content is commonly measured by Kjeldahl or combustion analysis, while moisture and ash are determined by gravimetric methods. Peptide molecular weight distribution is often assessed by size exclusion chromatography or mass spectrometry. The extent of hydrolysis can be estimated by titration, trinitrobenzenesulfonic acid assays, or formol titration. Because hydrolysis produces a complex mixture, no single test captures every relevant property, and laboratories often combine several methods.
Allergen testing is relevant because whey is a milk-derived ingredient. Immunoassays can detect residual milk proteins, but hydrolysis may alter or destroy antibody-binding sites, leading to false negatives or underestimation. Liquid chromatography with tandem mass spectrometry can identify specific peptide markers and is less dependent on intact protein epitopes. Regulatory labeling rules for milk allergens vary by country, and a product described as hydrolyzed is not automatically exempt from allergen declaration. For infants, specialized formulas require strict control of protein molecular weight and sterility, which adds testing beyond routine composition.
| Property | Value | Notes |
|---|---|---|
| Moisture content | Typically below 6% | Higher moisture increases caking, browning, and microbial risk. |
| Water activity | Often below 0.6 | Low water activity limits microbial growth in dry powders. |
| Typical storage temperature | 15–25 °C | Keep sealed, dry, and away from strong odors and direct light. |
| Protein quantification | Kjeldahl or Dumas combustion | Measures total nitrogen; a conversion factor estimates protein. |
| Peptide size analysis | Size-exclusion chromatography or mass spectrometry | Results depend on method, calibration, and sample preparation. |
Regulatory and labeling frameworks vary by country. In the United States, whey protein hydrolysate may be regulated as a food ingredient or a dietary supplement ingredient depending on intended use. In the European Union, it falls under general food law, with additional rules for infant formula and foods for special medical purposes. A claim of hypoallergenicity is not established by hydrolysis alone and generally requires clinical evidence. Open questions remain about how degree of hydrolysis relates to bitterness, nitrogen absorption, and residual allergenicity across different products and processing methods.
Quality control for whey protein hydrolysate combines compositional and molecular tests. Protein content is measured by Kjeldahl or Dumas nitrogen determination. Moisture, ash, fat, and lactose are checked with standard food methods. The degree of hydrolysis is estimated by TNBS, OPA, or pH-stat procedures that quantify free amino groups or released protons. Molecular weight distribution is examined by size-exclusion chromatography or SDS-PAGE. These tests describe average peptide size rather than exact peptide sequences, and results depend on standards and calibration.
Quality control for hydrolysate ingredients focuses on identity, purity, and consistency, with specifications that may include total protein, hydrolysis level, molecular weight distribution, microbiological limits, heavy metals, and allergen labeling. In some jurisdictions, partially and extensively hydrolyzed formulas are regulated as foods for special dietary uses or as infant formula ingredients. Regulatory status varies by country and intended use. Documentation such as certificates of analysis, safety data sheets, and method validation records supports traceability. Open questions remain about standardizing hydrolysis measurements across suppliers and laboratories.
Testing hydrolysate powders typically begins with proximate analysis for moisture, ash, fat, and total nitrogen. Protein content is calculated from nitrogen using a conversion factor, most often Kjeldahl or Dumas combustion. Peptide size distribution is assessed by size-exclusion chromatography, reversed-phase HPLC, or mass spectrometry. Sodium dodecyl sulfate polyacrylamide gel electrophoresis can show residual intact protein bands. Free amino groups may be quantified by colorimetric assays to estimate cleavage extent, though different methods and laboratories are not always directly comparable.
Dry hydrolysate powders are generally stable when kept cool, dry, and sealed, while moisture uptake can cause caking, Maillard browning, and loss of solubility. Higher temperatures accelerate these changes and may alter flavor. Recommended storage conditions often fall between 15 and 25 degrees Celsius with relative humidity below 60 percent. Once reconstituted, liquid hydrolysate solutions support microbial growth and may develop bitterness or haze over time. Packaging in moisture-barrier containers with desiccants helps maintain quality during transport and warehouse storage.
Asparagopsis requires very little processing. It is harvested from a seaweed farm then uses freeze drying or controlled drying to preserve as much bioactivity as possible. This can then be packaged and transported as required. Alternatively, it can be steeped in an edible oil, such as canola. Homogeneity of seaweed biomass within the feed must be maintained to ensure uniform intake for consistent effect. Asparagopsis is either one of two species: Asparagopsis taxiformis or Asparagopsis armata. Both species have very similar biochemistry and thus negligible difference in performance as an additive. The main distinction between either species is the conditions that each flourishes in. A. taxiformis thrives in tropical and subtropical climates and can be found in Australian coastal waters, predominantly in northern Queensland and Western Australia. A. armata thrives in temperate climates and is found naturally in the Mediterranean Sea and Tasman Sea.
==== MiniMed 670G ==== In September 2016, the FDA approved the Medtronic MiniMed 670G, which was the first approved hybrid closed loop system. The device automatically adjusts a patient's basal insulin delivery. It is made up of a continuous glucose monitor, an insulin pump, and a glucose meter for calibration. It automatically functions to modify the level of insulin delivery based on the detection of blood glucose levels by continuous monitor. It does this by sending the blood glucose data through an algorithm that analyzes and makes the subsequent adjustments. The system has two modes. Manual mode lets the user choose the rate at which basal insulin is delivered. Auto mode regulates basal insulin levels from the CGM readings every five minutes.
=== Preclinical === AC-203 – unspecified – alopecia areata – cell death modulator ADA-308 – topical – alopecia – androgen receptor antagonist BMD-1141 (BMD-1341) – subcutaneous injection – alopecia – parathyroid hormone receptor agonist Crebankitug (ZB-168) – parenteral – alopecia areata – interleukin 7 receptor α subunit inhibitor, thymic stromal lymphopoietin inhibitor CS-12192 – oral – alopecia areata – Janus kinase 1 inhibitor, Janus kinase 3 inhibitor, TBK1 protein inhibitor ES-135 – parenteral – alopecia – fibroblast growth factor replacement FB-102 – unknown – alopecia areata – interleukin-2 receptor β subunit antagonist HCW-9302 – injection – alopecia areata – interleukin 2 replacement MAX-40070 (MAX-3) – topical – alopecia areata – Janus kinase inhibitor, TYK2 kinase inhibitor MEI-004 – unknown – alopecia – undefined mechanism of action Oxymetazoline (DA-020) – topical – alopecia – α1-adrenergic receptor agonist Phenylephrine/synephrine/tyramine (DA-007) – topical – alopecia – combination of phenylephrine (α1-adrenergic receptor agonist), synephrine (α1-adrenergic receptor agonist), and tyramine (norepinephrine–dopamine releasing agent) YR-001 – topical – alopecia – ion channel antagonist
== Characterization == Nanoparticle drug delivery focuses on maximizing drug efficacy and minimizing cytotoxicity. Fine-tuning nanoparticle properties for effective drug delivery involves addressing the following factors. The surface-area-to-volume ratio of nanoparticles can be altered to allow for more ligand binding to the surface. Increasing ligand binding efficiency can decrease dosage and minimize nanoparticle toxicity. Minimizing dosage or dosage frequency also lowers the mass of nanoparticle per mass of drug, thus achieving greater efficiency. Surface functionalization of nanoparticles is another important design aspect and is often accomplished by bioconjugation or passive adsorption of molecules onto the nanoparticle surface. By functionalizing nanoparticle surfaces with ligands that enhance drug binding, suppress immune response, or provide targeting/controlled release capabilities, both a greater efficacy and lower toxicity are achieved. Efficacy is increased as more drug is delivered to the target site, and toxic side effects are lowered by minimizing the total level of drug in the body. The composition of the nanoparticle can be chosen according to the target environment or desired effect. For example, liposome-based nanoparticles can be biologically degraded after delivery, thus minimizing the risk of accumulation and toxicity after the therapeutic cargo has been released. Metal nanoparticles, such as gold nanoparticles, have optical qualities(also described in nanomaterials) that allow for less invasive imaging techniques.
== Medicines == Treatments based on monoclonal antibodies have been produced related to CGRP or CGRP receptors. They have been shown to be effective in patients who experience migraine headaches, both with and without aura, and both episodic and chronic cluster headache. These are the first class of preventive medications originally designed and approved for people with migraine. Due to the nature of the monoclonal antibodies, they must be administered parenterally, preferably by injection. The first CGRP related medication approved by the FDA is called erenumab (trade name Aimovig), produced by pharmaceutical company Amgen and Novartis. It interacts with the CGRP receptor. It is injected once monthly with a dose of 70 or 140 mg. Few adverse effects were reported (most related to injection site reactions) and patients had a significant reduction in migraines. The second approved by the FDA is fremanezumab (trade name Ajovy), produced by the Teva Pharmaceuticals company. It interacts with the CGRP protein, whose expression is related to migraine attacks. It may be administered monthly or every three months, giving options for users. Trials have shown a reduction of greater than 50% of migraine days for those who responded. There were few significant side effects during trials, most related to injection site reactions. The third CGRP medication approved by the FDA is galcanezumab (trade name Emgality), produced by the Eli Lilly and Company. It interacts with the CGRP protein, whose expression is related to migraine attacks.
Sources: en.wikipedia.org
Bone is a form of connective tissue found in the body, composed largely of hardened hydroxyapatite-containing collagen. In larger mammals, it is arranged in osteon regions. Bone matrix allows mineral salts such as calcium to be stored and provides protection for internal organs and support for locomotion.
== Research == A 2003 systematic review found that kava extract reduced anxiety symptoms compared to placebo, with a small effect size and mostly mild, transient side effects. Kava may help with anxiety after several weeks of use. Meta-analyses suggest kava can reduce anxiety symptoms – sometimes comparably to medications like oxazepam and buspirone – with strongest evidence seen in multiweek studies using aqueous extracts for generalized anxiety disorder, although results were mixed and standardized trials are limited. Current evidence does not support its effectiveness for generalized anxiety disorder or other conditions. Kava has no proven effects on cancer, cognitive function, or microbial infections. Kava generally does not impair cognition at therapeutic doses and may enhance attention and memory at lower doses, but may reduce visual attention at higher or recreational doses; heterogeneity in study design, dosage, preparation, and small sample sizes limits definitive conclusions. A study of heavy and long-term kava users in northern Australia found no evidence of cognitive or brain dysfunction despite some physical health effects, including liver enzyme elevation and skin changes.
== See also == Bibliography of Joe Biden Electoral history of Joe Biden List of presidents of the United States List of presidents of the United States by previous experience List of things named after Joe Biden
== Additional proteins performing this function == APOBEC1 APOBEC3A-H, APOBEC3G - affects HIV Activation-induced cytidine deaminase (AICDA) Cytidine deaminase (CDA) dCMP deaminase (DCTD) AMP deaminase (AMPD1) Adenosine Deaminase acting on tRNA (ADAT) Adenosine Deaminase acting on dsRNA (ADAR) Double-stranded RNA-specific editase 1 (ADARB1) Adenosine Deaminase acting on mononucleotides (ADA) Guanine Deaminase (GDA)
==== Genetic origin ==== Hereditary gingival fibromatosis is the main example of a genetic disease causing gingival lesions. There is fibrous enlargement of the gums which may completely cover the teeth and interfere with the normal eruption of teeth in growing children.
Sources: en.wikipedia.org
All four simple nitrogen trihalides are known. A few mixed halides and hydrohalides are known, but are mostly unstable; examples include NClF2, NCl2F, NBrF2, NF2H, NFH2, NCl2H, and NClH2. Nitrogen trifluoride (NF3, first prepared in 1928) is a colourless and odourless gas that is thermodynamically stable, and most readily produced by the electrolysis of molten ammonium fluoride dissolved in anhydrous hydrogen fluoride. Like carbon tetrafluoride, it is not at all reactive and is stable in water or dilute aqueous acids or alkalis. Only when heated does it act as a fluorinating agent, and it reacts with copper, arsenic, antimony, and bismuth on contact at high temperatures to give tetrafluorohydrazine (N2F4). The cations NF+4 and N2F+3 are also known (the latter from reacting tetrafluorohydrazine with strong fluoride-acceptors such as arsenic pentafluoride), as is ONF3, which has aroused interest due to the short N–O distance implying partial double bonding and the highly polar and long N–F bond. Tetrafluorohydrazine, unlike hydrazine itself, can dissociate at room temperature and above to give the radical NF2•. Fluorine azide (FN3) is very explosive and thermally unstable. Dinitrogen difluoride (N2F2) exists as thermally interconvertible cis and trans isomers, and was first found as a product of the thermal decomposition of FN3. Nitrogen trichloride (NCl3) is a dense, volatile, and explosive liquid whose physical properties are similar to those of carbon tetrachloride, although one difference is that NCl3 is easily hydrolysed by water while CCl4 is not.
== Strong bases == A strong base is a base that is quantitatively protonated upon exposure to water. This complete protonation is a result of the leveling effect. The term "strong base" can lead to confusion, since in this case "strong" is a category of base rather than a qualitative description. For example, guanidine is a very basic molecule, but it does not meet the definition of a strong base because it is not fully protonated by water. Common examples of strong bases include hydroxides of alkali metals and alkaline earth metals, like sodium hydroxide and calcium hydroxide, respectively. Due to their low solubility, some bases, such as alkaline earth hydroxides, can be used when the solubility factor is not taken into account. One advantage of this low solubility is that "many antacids were suspensions of metal hydroxides such as aluminium hydroxide and magnesium hydroxide"; compounds with low solubility and the ability to stop an increase in the concentration of the hydroxide ion, preventing the harm of the tissues in the mouth, oesophagus, and stomach. As the reaction continues and the salts dissolve, the stomach acid reacts with the hydroxide produced by the suspensions. Strong bases hydrolyze in water completely due to the leveling effect. In this process, the water molecule acts as an acid to protonate the base, resulting in the formation of a hydroxide anion. Under anhydrous conditions, some strong bases can even deprotonate weakly acidic C–H bonds. Here is a list of several strong bases:
Metrohm AG is an internationally active producer of precision instruments for chemical analysis, in particular ion analysis, based in Herisau, Switzerland. Metrohm is the leading manufacturer of titration devices and one of the two biggest manufacturers of ion chromatography systems. Besides, the product range includes systems for near-infrared and Raman spectroscopy, electrochemical measurements, and process analytics. These products are used in industries such as pharmaceuticals, food, chemicals, energy, and environmental analysis.
== Releasing hormones == Releasing hormones also known as hypophysiotropic or hypothalamic hormones are synthesized by different kinds of specialized neurons in the hypothalamus. They are then transported along neuronal axons to their axon terminals forming the bulk of the median eminence, where they are stored and released into the hypophyseal portal system. They then rapidly reach the anterior pituitary where they exert their hormonal action. The residual hormones pass into the systemic circulation where they are diluted, degraded and have comparatively little effects. The synthesis, control, and release of those hormones is co-regulated by hormonal, local and synaptic signals (neurotransmitters). The neurons secreting various hormones have been found to discharge impulses in burst, causing a pulsatile release which is more efficient than a continuous release. Hypophysiotropic hormones include:
=== Effects on the economy === Beyond its social and political toll, the Mexican drug war has also had significant economic consequences. It has increased costs for businesses, disrupted supply chains, and raised insurance premiums. Small and medium businesses in cartel-dominated areas are affected by widespread extortion, known as piso, while multinational corporations have delayed or reduced investments due to security risks. At the government level, the costs of military deployment and police expansion have represented a growing fiscal burden. Given Mexico's high rates of tax noncompliance, these expenditures have further constrained public finances and limited funding for other essential services. Finance Minister Agustín Carstens said that the deteriorating security alone is reducing gross domestic product annually by 1% in Mexico, Latin America's second-largest economy.
Sources: en.wikipedia.org
Peptide size is commonly estimated by size-exclusion chromatography, gel electrophoresis, or mass spectrometry. These techniques separate or identify molecules according to mass or hydrodynamic volume. Results depend on calibration and method conditions, so they are best compared within the same analytical protocol.
Clumping usually reflects moisture uptake by hygroscopic peptides and residual lactose. High humidity, temperature fluctuations, and damaged packaging can worsen caking. Sealed containers with desiccant and controlled storage reduce the problem.
No universal reference method exists for all hydrolysates, although several established assays are used. Different methods measure different chemical features and can produce different numerical values. For this reason, specifications should state the assay and laboratory conditions.
Size exclusion chromatography separates peptides by molecular size in solution, and mass spectrometry can provide more detailed mass information. Results are usually reported as a distribution rather than a single value. Method choice and calibration affect the reported range.